GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neurocrine Biosciences Inc (BSP:N1BI34) » Definitions » 6-1 Month Momentum %

Neurocrine Biosciences (BSP:N1BI34) 6-1 Month Momentum %

: 23.36% (As of Today)
View and export this data going back to 2020. Start your Free Trial

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-04-19), Neurocrine Biosciences's 6-1 Month Momentum % is 23.36%.

The industry rank for Neurocrine Biosciences's 6-1 Month Momentum % or its related term are showing as below:

BSP:N1BI34's 6-1 Month Momentum % is ranked better than
77.98% of 1117 companies
in the Drug Manufacturers industry
Industry Median: -1.21 vs BSP:N1BI34: 23.36

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Neurocrine Biosciences's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neurocrine Biosciences 6-1 Month Momentum % Distribution

For the Drug Manufacturers industry and Healthcare sector, Neurocrine Biosciences's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Neurocrine Biosciences's 6-1 Month Momentum % falls into.



Neurocrine Biosciences  (BSP:N1BI34) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neurocrine Biosciences  (BSP:N1BI34) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Neurocrine Biosciences 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Neurocrine Biosciences's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurocrine Biosciences (BSP:N1BI34) Business Description

Traded in Other Exchanges
Address
12780 El Camino Real, San Diego, CA, USA, 92130
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.

Neurocrine Biosciences (BSP:N1BI34) Headlines

No Headlines